Gene · 339
APOBEC1: apolipoprotein B mRNA editing enzyme catalytic subunit 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. APOBEC1: apolipoprotein B mRNA editing enzyme catalytic subunit 1. Genes, record 339. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/339
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P41238 | C->U-editing enzyme APOBEC-1 | 236 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents219
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4828972 A1 | 2026-10-28 | 48 | P41238 | Espacenet |
| EP 4828972 A1 | 2026-10-28 | 580 | P41238 | Espacenet |
| JP 2026525611 A | 2026-07-31 | 82 | P41238 | Espacenet |
| JP 2026525612 A | 2026-07-31 | 515 | P41238 | Espacenet |
| EP 4777618 A1 | 2026-07-22 | 48 | P41238 | Espacenet |
| EP 4777618 A1 | 2026-07-22 | 580 | P41238 | Espacenet |
| JP 2026116287 A | 2026-07-09 | 279 | P41238 | Espacenet |
| EP 4762095 A1 | 2026-06-24 | 48 | P41238 | Espacenet |
| EP 4762177 A1 | 2026-06-24 | 41 | P41238 | Espacenet |
| EP 4753741 A1 | 2026-06-10 | 48 | P41238 | Espacenet |
1 to 10 of 219
See all 219 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,054
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOBEC1 papers | Newest fiscal year |
|---|---|---|---|
| P30DK052574 | Host-environment interactions in the pathophysiology of digestive disease | 28 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 16 | 2025 |
| P30DK042086 | Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID) | 13 | 2025 |
| R35GM118062 | Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P01CA234228 | APOBEC Mutagenesis in Cancer | 7 | 2025 |
| T32CA009138 | Molecular, Genetic and Cellular Targets of Cancer Training Program | 7 | 2025 |
| R01AI150524 | Structural Basis of APOBEC Functions and HIV Restriction | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 1,054Source NIH's project files
See all 1,054 nih grantsPapers1,336
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mRNA editing of the Alzheimer's risk gene APOE. | bioRxiv | 2026 | 42818221 | PubTator, text mining | PubMed |
| CRYSPER and CUREIPES: two new molecular tools enabling analysis of RNA splicing and C-to-U RNA editing-inducible protein expression at single cell resolution. | Nucleic Acids Res | 2026 | 42779099 | PubTator, text mining | PubMed |
| Mapping Allele-specific RBP Binding by a Machine Learning Coupled RNA Editing Strategy in Human Embryonic Stem Cells. | Genomics Proteomics Bioinformatics | 2026 | 42671340 | PubTator, text mining | PubMed |
| Potentially regulating the ApoB RNA editosome via FXR activation: The natural compound continentalic acid alleviates hepatic fibrogenesis. | Phytomedicine | 2026 | 42462532 | PubTator, text mining | PubMed |
| Deciphering APOBEC1 in Avians: unravelling loss events and functional insights. | Immunogenetics | 2026 | 42289512 | PubTator, text mining | PubMed |
| Natural Resistance to Ovarian Hyperstimulation Syndrome in Estrildid Finches Reveals Macrophage GPR183 as a Potential Therapeutic Target. | Adv Sci (Weinh) | 2026 | 42085637 | PubTator, text mining | PubMed |
| The Role of Nuclear APOBEC Enzymes in Neoplastic Progression of Ulcerative Colitis. | Clin Exp Gastroenterol | 2026 | 42006844 | PubTator, text mining | PubMed |
| HAMMER: hairpin-based APOBEC3A-mediated mRNA editing reporter. | Nucleic Acids Res | 2026 | 41925228 | PubTator, text mining | PubMed |
| An efficient C-to-U RNA recorder as a tool for profiling targets of RNA-binding proteins. | N Biotechnol | 2026 | 41839235 | PubTator, text mining | PubMed |
| Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions. | Front Immunol | 2026 | 41756300 | PubTator, text mining | PubMed |
1 to 10 of 1,336
See all 1,336 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/339
GET https://conductscience.org/api/genes/v1/339/patents?page=2